Medicare Enrolled

Dr. Hemant Kalia, MD MPH

Interventional Pain Medicine Physician · Rochester, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
500 HELENDALE RD STE LL20, Rochester, NY 14609
5856007246
In practice since 2007 (19 years)
NPI: 1689879959 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kalia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kalia

Dr. Hemant Kalia is an interventional pain medicine physician in Rochester, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kalia performed 538 Medicare services across 422 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kalia received a total of $122,920 from 22 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kalia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 538 Medicare services $122,920 industry payments

Medicare Practice Summary

Medicare Utilization ↗
538
Medicare services
Bottom 27% in NY for interventional pain medicine physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
422
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
233 $58 $153
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
219 $188 $596
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $67 $205
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $92 $288
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $87 $313
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$122,920
Total received (2018-2024)
Avg $17,560/year across 7 years
Top 7% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$107,639 (87.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,480 (10.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,801 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,075
2023
$28,707
2022
$53,726
2021
$9,198
2020
$773
2019
$1,952
2018
$2,489

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Averitas Pharma Inc.
$10,415
Abbott Laboratories
$9,535
TerSera Therapeutics LLC
$2,801
SI-BONE, INC.
$2,092
SPR Therapeutics, Inc
$851
Saluda Medical Americas, Inc.
$166
Stratus Medical, LLC
$147
Merit Medical Systems Inc
$30
VERTEX PHARMACEUTICALS INCORPORATED
$23
Curonix LLC
$16
Top 3 companies account for 87.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$86,715
Averitas Pharma Inc.
$20,320
TerSera Therapeutics LLC
$2,877
Nevro Corp.
$2,548
SI-BONE, INC.
$2,092
GRT US Holding, Inc.
$2,000
SPR Therapeutics, Inc
$1,341
Nalu Medical, Inc.
$1,240
Vertos Medical, Inc.
$1,094
Medtronic USA, Inc.
$771
Boston Scientific Corporation
$735
Medtronic, Inc.
$326
BOSTON SCIENTIFIC CORPORATION
$237
Saluda Medical Americas, Inc.
$166
Spinal Simplicity, LLC
$154
Stratus Medical, LLC
$147
PFIZER INC.
$40
Merit Medical Systems Inc
$30
Relievant Medsystems, Inc.
$29
VERTEX PHARMACEUTICALS INCORPORATED
$23
Bioventus LLC
$18
Curonix LLC
$16
Top 3 companies account for 89.4% of all-time payments
Associated products mentioned in payments ›
AXIUM · Axium INS DRG IPG · Axium Sheath Braided DRG · CHANTIX · Durolane · ETERNA · EXCLAIM · Evoke · HA MINUTEMAN G3-R · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · IonicRF Generator · KYPHON Balloon Kyphoplasty · LAMITRODE · LYRICA · Lamitrode SCS Leads · Nalu Neurostimulation System · Nimbus · OCTRODE · Octrode SCS Leads · Omnia · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · PRODIGY · Prialt · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · QUTENZA · Qutenza · RESTORE · SCS IPGs · SCS leads · SPRINT PNS System · STAR Tumor Ablation System · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Superion · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional pain medicine physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for interventional pain medicine physician in NY.

Looking for an interventional pain medicine physician in Rochester?
Compare interventional pain medicine physicians in the Rochester area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional pain medicine physicians within 10 mi
2
Per 100K population
0.3
County median income
$74,409
Nearest hospital
ROCHESTER GENERAL HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kalia is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kalia experienced with drug screening test?
Based on Medicare claims data, Dr. Kalia performed 233 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalia receive payments from pharmaceutical companies?
Yes. Dr. Kalia received a total of $122,920 from 22 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalia's costs compare to other interventional pain medicine physicians in Rochester?
Dr. Kalia's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →